The Lilac Device Trial - IMPACT: A Clinical Investigation on IMproving Peripheral Neuropathy Induced by Chemotherapy With Advanced Compression Technology - A Safety and Efficacy Study

Abroad (travel likely)Recruiting

Conditions

Chemotherapy Induced Peripheral Neuropathy (CIPN)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Palomar Health (Topography), Poway, California, United States

  • Eastern Connecticut Hematology Oncology, Norwich, Connecticut, United States

    Contact: Principal Investigator (Dr. Dennis Slater)
  • Hialeah Hospital, Hialeah, Florida, United States

    Contact: Study coordinator (Adrian Almarales) · aalmarales@bioresearchpartner.com · 833-489-4968
    Contact: Principal Investigator (Dr. Luis Rangel)
  • Hawaii Cancer Care, Honolulu, Hawaii, United States

    Contact: Study coordinator (Isobel Webster) · isobel.webster@AONcology.com · 808-524-6115
    Contact: Principal Investigator (Dr. Ashley Springer)
  • Hope and Healing Cancer Services, Hinsdale, Illinois, United States

    Contact: Study coordinator (Ava Baftirovska) · abaftirovska@hopenheal.care · (630) 560-0121
    Contact: Principal Investigator (Dr. Srilata Gundala)
  • Parkview Cancer Institute, Fort Wayne, Indiana, United States

    Contact: Principal Investigator (Dr. Joseph McCollom)
  • Health Partners Frauenshuh Cancer Center, Minneapolis, Minnesota, United States

    Contact: Study coordinator (Jacquelyn Christenson) · jacquelyn.christenson@parknicollet.com · 612-341-4800
    Contact: Principal Investigator (Dr. Rachel Lerner)
  • Fairview Masonic Cancer Clinic, University of Minnesota, Minneapolis, Minnesota, United States

    Contact: Principal Investigator (Dr. Melissa Geller)
  • Astera Cancer Care, East Brunswick, New Jersey, United States

    Contact: Study coordinator (Percy Yeung) · Percy.yeung@asterahealthcare.org · 732 387 3378
    Contact: Principal Investigator (Dr. Siu-Long Yao)
  • Inspira Medical Center Mullica Hill, Mullica Hill, New Jersey, United States

    Contact: Principal Investigator (Dr. Erev Tubb)
  • Inspira Health - Vineland, Vineland, New Jersey, United States

    Contact: Principal Investigator (Dr. Mylene Go)
  • New York Cancer and Blood Specialists, New York, New York, United States

    Contact: Principal Investigator (Dr. Richard Zuniga)
  • Springfield Regional Cancer Center, Springfield, Ohio, United States

    Contact: Study coordinator (Tracy Adrian) · tadrian@sorcc.org · 937-323-5554
    Contact: Principal Investigator (Dr. Zaw Min Bo)
  • Mercy Health St. Elizabeth Hospital, Youngstown, Ohio, United States

    Contact: Study coordinator (Jo Wilms) · JWilms@mercy.com · 330-240-4616
    Contact: Principal Investigator (Dr. James Kim)
  • Providence Cancer Institute, Portland, Oregon, United States

    Contact: Principal Investigator (Dr. David Page)
  • Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

    Contact: Principal Investigator (Dr. Rajiv Agarwal)
  • Hospital Sisters Health System - St.Vincent & St.Mary's, Green Bay, Wisconsin, United States

    Contact: Study coordinator (Jessica Franzke) · Jessica.Franzke@hshs.org · 920-433-8795
    Study coordinator · brian.burnette@hshs.org
    Contact: Principal Investigator (Dr. Brian Burnette)
  • St. James Hospital, Dublin, Dublin, Ireland

    Contact: Principal Investigator (Professor Maeve Lowery)